News Results for Glaxosmithkline (GSK)

Emma Walmsley, Director, bought 8 shares in the company on the 10th September 2020 at a price of 15.203500p. The Director now holds 779,137 shares. Story provided by StockMarketWire.com Director...

Emma Walmsley, Director, has transferred in 8 shares in the company on the 10th September 2020 at a price of 0.000000p. The Director now holds 779,145 shares. Story provided by...

UK shares turned-down sharply on Thursday afternoon following US stocks lower on the biggest tech stock weakness seen since March with the Nasdaq 100 falling more than 5%. After strong gains over...

UK markets have been lifted following an appearance by Bank of England governor Andrew Bailey before the Treasury Select Committee yesterday (2 September) in which he said UK interest rates could...

Drugmakers GSK and Sanofi announced they would begin a phase 1/2 clinical trial for their potential COVID-19 vaccine and expected first results from the study in early December 2020. Positive...

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1725p). Story provided by StockMarketWire.com Broker...

Emma Walmsley, Director, has transferred in 8 shares in the company on the 11th August 2020 at a price of 0.000000p. The Director now holds 779,129 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, bought 8 shares in the company on the 11th August 2020 at a price of 15.978500p. The Director now holds 779,121 shares. Story provided by StockMarketWire.com Director...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by StockMarketWire.com Broker Forecasts data provided...

Pharmaceutical company GlaxoSmithKline said the US Food and Drug Administration had approved its a drug used to treat blood cancer patients. The drug, BLENREP, was approved as s a monotherapy...

UK stocks reversed opening softness to put in a late morning surge on Monday as investors shrugged-off geopolitical worries and soaring losses posted by HSBC, the UK's largest listed bank. At...

UK stocks opened lower on Monday after HSBC revealed hefty credit losses related to the Covid-19 crisis and aerospace engineering Senior announced another round of job cuts. At 0828, the benchmark...

Sanofi and GlaxoSmithKline said they were in 'advanced discussions' with the European Commission to supply up to 300m doses of a Covid-19 vaccine. The vaccine candidate developed by Sanofi in...

Pharmaceutical company GlaxoSmithKline said it and partner Sanofi had been selected by the US government to participate in the 'operation warp speed' effort to develop a vaccine for Covid-19. The...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1850p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2020p (from 2060p). Story provided by StockMarketWire.com Broker Forecasts...

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1860p). Story provided by StockMarketWire.com Broker Forecasts...

Jesse Goodman, Director, bought 769 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 8,464 shares representing 0.00% of the shares in issue. Story...

Urs Rohner, Director, bought 531 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 12,129 shares representing 0.00% of the shares in issue. Story...

Vivienne Cox, Non Executive Director, bought 688 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 6,577 shares representing 0.00% of the shares in...

Charles Bancroft, Non Executive Director, bought 1,002 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 1,002 shares representing 0.00% of the shares in...

Jonathan Symonds, Chairman, bought 2,753 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 38,311 shares representing 0.00% of the shares in issue. Story...

Manvinder Singh Banga, Non Executive Director, bought 570 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 62,421 shares representing 0.00% of the shares...

Judy Lewent, Non Executive Director, bought 808 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 29,451 shares representing 0.00% of the shares in...

Laurie Glimcher, Non Executive Director, bought 2,445 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 17,874 shares representing 0.00% of the shares in...

Lynn Elsenhans, Non Executive Director, bought 1,301 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 41,886 shares representing 0.00% of the shares in...

UK stocks ended Wednesday virtually flat ahead of the US Federal Reserve vote on interest rates this evening. Market indecision plagued the FTSE 100, but Wall Street was in positive mood with the...

Pharmaceutical company GlaxoSmithKline said that meeting its annual earnings guidance was contingent on the timing of a recovery in vaccine demand, a slump in which drove a fall in its...

UK stocks moved higher by midday on Wednesday as investors await the latest update on US monetary policy from the Fed, due later on Wednesday. At 1150, Britain's benchmark FTSE 100 index was up...

Pharmaceutical companies GlaxoSmithKline and Sanofi reached an agreement with the UK government to supply up to 60m doses of a potential Covid-19 vaccine. The vaccine candidate used Sanofi's...

Emma Walmsley, Director, has transferred in 277,623 shares in the company on the 27th July 2020 at a price of 0.000000p. The Director now holds 779,113 shares. Story provided by...

UK stocks traded lower on Monday, with oil companies weighing, as mounting Covid-19 cases stoked fears of a short-lived recovery in the global economy. At 11.35, the benchmark FTSE 100 index was...

UK stocks opened lower on Monday, with oil companies weighing, as mounting Covid-19 cases stoke fears of a short-lived recovery in the global economy. At 0826, the benchmark FTSE 100 index was...

Pharmaceutical giant GlaxoSmithKline invested £104m for a 10% stake in biotech company CureVac, while both companies agreed to develop vaccines and antibodies targeting infectious diseases. The...

UK markets closed sharply higher on Wednesday, bolstered by a firm opening on Wall Street and early promise from a Covid-19 vaccine candidate. Early trading across the pond saw varying gains for...

UK markets continued to climb through late morning on Wednesday, boosted by a firm overnight showing on Wall Street and early promise from a Covid-19 vaccine candidate. Pharmaceutical company...

UK stocks opened higher on Wednesday after a vaccine candidate for Covid-19 showed promising early trail results. At 0829, the benchmark FTSE 100 index was up 55.84 points, or 0.9%, at 6,235.59....

Pharmaceutical company GlaxoSmithKline said an advisory committee of the US Food and Drug Administration had unanimously voted in favor of the use of cancer therapy belantamab mafodotin . The vote...

A late rally for stocks saw the UK's major markets end the trading session higher on Monday despite evidence of economic recovery offset by concerns of a potential resurgence in Covid-19 cases. At...

UK markets made mixed progress through the morning in Monday trade as investors continue to weigh the implications economic recovery against a potential resurgence in Covid-19 cases. At 12.30pm,...

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1840p (from 1760p). Story provided by StockMarketWire.com Broker Forecasts data...

The FTSE 100 passed an important psychological hurdle on Monday as it jumped over the 6,000 mark for the first time in almost three weeks amid positive news from a coronavirus vaccine trial. The...

UK stocks made strong gains on Monday as more countries continued to take tentative steps to emerge from coronavirus lockdowns. A surge in oil prices also helped, along with data which showed that...

GlaxoSmithKline said ViiV Healthcare, a joint venture with Pfizer, would end its clinical study of an HIV jab early after achieving its primary goal and showing higher efficacy in preventing the...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1920p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

GlaxoSmithKline said it expected to receive higher proceeds from the sale of its 5.7% stake Indian public company Hindustan Unilever following an appreciation in the latter's share price. 'When...

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1750p). Story provided by StockMarketWire.com Broker...

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2060p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1550p (from 1450p). Story provided by StockMarketWire.com Broker...

Pharma giant GSK said an application for an oral drug to treat women with ovarian cancer had been approved by US health authorities. The US Food and Drug Administration approved the company's new...

Pharmaceutical company GlaxoSmithKline posted a 41% jump in first-quarter earnings after drug sales were boosted by stockpiling amid the Covid-19 pandemic. Operating profit for the three months...

Emma Walmsley, Chief Executive Officer, has re-invested 2,407 shares in the company on the 14th April 2020 at a price of 1567.85p. The Director now holds 755,223 shares. Story provided by...

Emma Walmsley, Chief Executive Officer, has re-invested 2,712 shares in the company on the 14th April 2020 at a price of 1544.20p. The Director now holds 752,816 shares. Story provided by...

Iain Mackay, Executive Director, has re-invested 524 shares in the company on the 14th April 2020 at a price of 1544.20p. The Director now holds 524 shares representing 0.00% of the shares in...

GlaxoSmithKline said it was planning to team up with rival pharmaceutical company Sanofi to develop a vaccine for Covid-19. The two companies had signed a letter of intent to enter into a...

GlaxoSmithKline agreed to buy a stake in Vir Biotechnology for $250m as part of a wider collaboration to development treatments for coronaviruses, including SARS-CoV-2, the virus that causes...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data...

GlaxoSmithKline had completed the sale of Indian consumer healthcare assets including the Horlicks brands to Unilever, the companies said on Wednesday. The deal, first announced in December 2018,...

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1530p (from 1830p). Story provided by StockMarketWire.com Broker Forecasts data...

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1450p (from 1550p). Story provided by StockMarketWire.com Broker...

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1725p (from 1740p). Story provided by StockMarketWire.com Broker...

Emma Walmsley, Chief Executive Officer, exercised 62,036 shares in the company on the 17th February 2020 at a price of 0.00p. The Director now holds 779,263 shares. Story provided by...

Emma Walmsley, Chief Executive Officer, exercised 62,036 shares in the company on the 17th February 2020 at a price of 0.00p. The Director now holds 779,263 shares. Story provided by...

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1840p (from 1930p). Story provided by StockMarketWire.com Broker Forecasts...

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2240p (from 2300p). Story provided by StockMarketWire.com Broker Forecasts...

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2050p (from 2110p). Story provided by StockMarketWire.com Broker Forecasts data...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided...

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1750p (from 1900p). Story provided by StockMarketWire.com Broker...

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1600p (from 1650p). Story provided by StockMarketWire.com Broker Forecasts...

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1550p (from 1650p). Story provided by StockMarketWire.com Broker...

Jonathan Symonds, Chairman, bought 11,730 shares in the company on the 6th February 2020 at a price of 1705.00p. The Director now holds 14,995 shares representing 0.00% of the shares in issue....

Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1773p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts...

Urs Rohner, Non Executive Director, bought 399 shares in the company on the 5th February 2020 at a price of 1800.00p. The Director now holds 9,499 shares representing 0.00% of the shares in issue....

Dr Vivienne Cox, Non Executive Director, received in lieu of fees/salary 295 shares in the company on the 5th February 2020 at a price of 1800.00p. The Director now holds 5,009 shares representing...

Jonathan Symonds, Chairman, bought 2,431 shares in the company on the 5th February 2020 at a price of 1800.00p. The Director now holds 3,265 shares representing 0.00% of the shares in issue....

Manvinder Banga, Non Executive Director, bought 399 shares in the company on the 5th February 2020 at a price of 1800.00p. The Director now holds 5,225 shares representing 0.00% of the shares in...

Pharmaceutical company GlaxoSmithKline reported a 30% rise in annual profit after it doubled of sales of its shingles vaccine, though if forecast weaker earnings in 2020. Pre-tax profit for the...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1930p (from 1890p). Story provided by StockMarketWire.com Broker...

The FTSE 100 index traded down 0.5% at 7,607 heading into the close, despite new highs in US markets, as pharmaceutical stocks reversed their gains of earlier this week, weighing on the benchmark....

The FTSE 100 index traded down 0.5% at 7,607 heading into the close, despite new highs in US markets, as pharmaceutical stocks reversed their gains of earlier this week, weighing on the benchmark....

The FTSE 100 index traded down 0.5% at 7,607 heading into the close, despite new highs in US markets, as pharmaceutical stocks reversed their gains of earlier this week, weighing on the benchmark....

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1860p (from 1800p). Story provided by StockMarketWire.com Broker...

Emma Walmsley, Chief Executive Officer, has re-invested 1,754 shares in the company on the 13th January 2020 at a price of 1790.20p. The Director now holds 717,220 shares. Story provided by...

Emma Walmsley, Chief Executive Officer, bought 1,371 shares in the company on the 14th January 2020 at a price of 1800.83p. The Director now holds 715,466 shares. Story provided by...

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2300p (from 2200p). Story provided by StockMarketWire.com Broker...

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1740p (from 1640p). Story provided by StockMarketWire.com Broker...

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1900p (from 1700p). Story provided by StockMarketWire.com Broker...

UK stocks opened moderately lower on Friday following a two-week winning streak triggered by Boris Johnson's election win. At 0854, the benchmark FTSE 100 index was down 15.37 points, or 0.2%, at...

GlaxoSmithKline confirmed that its ViiV Healthcare joint venture with Pfizer and Shionogi had received a so-called complete response letter from the US Food and Drug Administration rejecting an HIV...

Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1747p (from 1660p). Story provided by StockMarketWire.com Broker...

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2000p (from 1850p). Story provided by StockMarketWire.com Broker...

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1890p (from 1650p). Story provided by StockMarketWire.com Broker Forecasts...

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1650p (from 1645p). Story provided by StockMarketWire.com Broker Forecasts...

UBS today upgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to buy (from neutral) and raised its price target to 1900p (from 1610p). Story provided by StockMarketWire.com Broker...

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1890p (from 1510p). Story provided by StockMarketWire.com Broker...

Barclays Capital today reaffirms its equal weight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1650p (from 1600p). Story provided by StockMarketWire.com...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2000p (from 1850p). Story provided by StockMarketWire.com Broker Forecasts data...